← Every applicant
Hainan Poly FDA Approvals
20 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| BRIVARACETAMNew drugFeb 23, 2026SOLUTION, INTRAVENOUS |
| GADOTERIDOLNew drugFeb 11, 2025INJECTABLE, INJECTION |
| CYCLOPHOSPHAMIDENew drugDec 26, 2024INJECTABLE, INJECTION |
| CISATRACURIUM BESYLATE PRESERVATIVE FREENew drugAug 27, 2024INJECTABLE, INJECTION |
| DOXYCYCLINE HYCLATENew drugJun 21, 2024INJECTABLE, INJECTION |
| GADOTERATE MEGLUMINENew drugJun 17, 2024SOLUTION, INTRAVENOUS |
| PHENYLEPHRINE HYDROCHLORIDENew drugMar 14, 2024SOLUTION, INTRAVENOUS |
| CISATRACURIUM BESYLATENew drugMar 8, 2024INJECTABLE, INJECTION |
| LACOSAMIDENew drugFeb 13, 2024SOLUTION, INTRAVENOUS |
| ACYCLOVIR SODIUMNew drugJan 8, 2024INJECTABLE, INJECTION |
| IOPAMIDOLNew drugSep 27, 2023INJECTABLE, INJECTION |
| LEUCOVORIN CALCIUMNew drugJul 10, 2023INJECTABLE, INJECTION |
| IOPAMIDOLNew drugFeb 27, 2023INJECTABLE, INJECTION |
| TOBRAMYCIN SULFATENew drugFeb 1, 2023INJECTABLE, INJECTION |
| LINCOMYCIN HYDROCHLORIDENew drugDec 21, 2022INJECTABLE, INJECTION |
| DOBUTAMINE HYDROCHLORIDENew drugDec 21, 2022INJECTABLE, INJECTION |
| SODIUM NITROPRUSSIDENew drugAug 26, 2022SOLUTION, INTRAVENOUS |
| ESOMEPRAZOLE SODIUMNew drugFeb 10, 2022INJECTABLE, INTRAVENOUS |
| VANCOMYCIN HYDROCHLORIDENew drugNov 18, 2021INJECTABLE, INJECTION |
| BIVALIRUDINNew drugMay 28, 2021INJECTABLE, INTRAVENOUS |